[
  {
    "ts": null,
    "headline": "Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q2 2025 Update",
    "summary": "See an update on Prem Watsa's latest 13F portfolio moves, find out his top stock picks, global strategy, and key insights for focused, long-term investing.",
    "url": "https://finnhub.io/api/news?id=628bb2894b5e7b55dcceee727c68da960b38694f77e54a37375520f34a37c29b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757451534,
      "headline": "Tracking Prem Watsa's Fairfax Financial Holdings Portfolio - Q2 2025 Update",
      "id": 136680992,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1264256639/image_1264256639.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "See an update on Prem Watsa's latest 13F portfolio moves, find out his top stock picks, global strategy, and key insights for focused, long-term investing.",
      "url": "https://finnhub.io/api/news?id=628bb2894b5e7b55dcceee727c68da960b38694f77e54a37375520f34a37c29b"
    }
  },
  {
    "ts": null,
    "headline": "Molina Healthcare (MOH) Stock Trades Up, Here Is Why",
    "summary": "Shares of healthcare insurance company Molina Healthcare (NYSE:MOH) jumped 2.4% in the afternoon session after industry leader UnitedHealth indicated its business operations are performing well.",
    "url": "https://finnhub.io/api/news?id=6b980002619115a6c88f5360a31dd24c4b42f8151a28479dfa38da8684463a8f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757449860,
      "headline": "Molina Healthcare (MOH) Stock Trades Up, Here Is Why",
      "id": 136680838,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Shares of healthcare insurance company Molina Healthcare (NYSE:MOH) jumped 2.4% in the afternoon session after industry leader UnitedHealth indicated its business operations are performing well.",
      "url": "https://finnhub.io/api/news?id=6b980002619115a6c88f5360a31dd24c4b42f8151a28479dfa38da8684463a8f"
    }
  },
  {
    "ts": null,
    "headline": "Why CVS Health (CVS) Stock Is Up Today",
    "summary": "Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 2.9% in the afternoon session after broad positive sentiment in the healthcare sector was supported by a bullish analyst outlook.",
    "url": "https://finnhub.io/api/news?id=a76d1dd317562f929bf60b2e6fb01d384c3d74ffe24cc79873761acda9e61a15",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757449850,
      "headline": "Why CVS Health (CVS) Stock Is Up Today",
      "id": 136687341,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 2.9% in the afternoon session after broad positive sentiment in the healthcare sector was supported by a bullish analyst outlook.",
      "url": "https://finnhub.io/api/news?id=a76d1dd317562f929bf60b2e6fb01d384c3d74ffe24cc79873761acda9e61a15"
    }
  },
  {
    "ts": null,
    "headline": "CVS defended by Raymond James after stock drop",
    "summary": "Investing.com -- Raymond James analysts defended CVS Health after the stock fell about 4.8% on Monday, saying the move reflected “misinterpretation” of industry commentary rather than any change in company fundamentals.",
    "url": "https://finnhub.io/api/news?id=0882cd31c185a8170a9b81dd106ee6d4ba12670d900c2bc5c903ebdbb394f37d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757439495,
      "headline": "CVS defended by Raymond James after stock drop",
      "id": 136687342,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Investing.com -- Raymond James analysts defended CVS Health after the stock fell about 4.8% on Monday, saying the move reflected “misinterpretation” of industry commentary rather than any change in company fundamentals.",
      "url": "https://finnhub.io/api/news?id=0882cd31c185a8170a9b81dd106ee6d4ba12670d900c2bc5c903ebdbb394f37d"
    }
  },
  {
    "ts": null,
    "headline": "What the Trump Administration Partnership Means for Gilead Sciences Shares in 2025",
    "summary": "Considering what to do with Gilead Sciences stock right now? You are not alone. With shares closing at $115.88 and the company logging a robust 26.1% return since the start of the year, investors are balancing optimism with a healthy dose of caution. If you have watched Gilead, you have likely noticed its 90.5% return over three years and a stunning 111.2% over five. Clearly, something interesting is happening beneath the surface. The story in the headlines has been dramatic as well. Gilead’s...",
    "url": "https://finnhub.io/api/news?id=f25edbfbeb6af55223b18ecb8d44f15e7cac00a88d1a5aaa54a12e151a04396f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757418436,
      "headline": "What the Trump Administration Partnership Means for Gilead Sciences Shares in 2025",
      "id": 136687343,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Considering what to do with Gilead Sciences stock right now? You are not alone. With shares closing at $115.88 and the company logging a robust 26.1% return since the start of the year, investors are balancing optimism with a healthy dose of caution. If you have watched Gilead, you have likely noticed its 90.5% return over three years and a stunning 111.2% over five. Clearly, something interesting is happening beneath the surface. The story in the headlines has been dramatic as well. Gilead’s...",
      "url": "https://finnhub.io/api/news?id=f25edbfbeb6af55223b18ecb8d44f15e7cac00a88d1a5aaa54a12e151a04396f"
    }
  }
]